货号:A666741
同义名:
Dequalinium (chloride); NSC 166454
Dequalinium Chloride是一种 PKC 抑制剂,IC50 值为 7-18 μM,同时也是一种选择性钾通道阻滞剂,能阻止 apamin 敏感的 K+ 通道,IC50 为 1.1 μM。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | ALK1 ↓ ↑ | ALK2 ↓ ↑ | ALK3 ↓ ↑ | ALK4 ↓ ↑ | ALK6 ↓ ↑ | Smad3 ↓ ↑ | TGF-β ↓ ↑ | TGFβRI/ALK5 ↓ ↑ | TGFβRII ↓ ↑ | 其他靶点 | 纯度 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LDN193189 |
++++
ALK1, IC50: 0.8 nM |
++++
ALK2, IC50: 0.8 nM |
+++
ALK3, IC50: 5.3 nM |
+++
ALK6, IC50: 16.7 nM |
99%+ | ||||||||||||||
| LDN-212854 |
++++
ALK1, IC50: 2.4 nM |
++++
ALK2, IC50: 1.3 nM |
+
ALK3, IC50: 85.8 nM |
+
ALK4, IC50: 2133 nM |
+
ALK5, IC50: 9276 nM |
99%+ | |||||||||||||
| ML347 |
++
ALK1, IC50: 46 nM |
++
ALK2, IC50: 32 nM |
98% | ||||||||||||||||
| K02288 |
++++
ALK1, IC50: 1.8 nM |
++++
ALK2, IC50: 1.1 nM |
++
ALK3, IC50: 34.4 nM |
+++
ALK6, IC50: 6.4 nM |
99%+ | ||||||||||||||
| LDN-193189 2HCl |
++++
ALK1, IC50: 0.8 nM |
++++
ALK2, IC50: 0.8 nM |
+++
ALK3, IC50: 5.3 nM |
+++
ALK6, IC50: 16.7 nM |
99% | ||||||||||||||
| LDN-214117 |
++
ALK2, IC50: 24 nM |
98% | |||||||||||||||||
| DMH-1 |
+
ALK2, IC50: 107.9 nM |
99%+ | |||||||||||||||||
| SB-505124 |
+
ALK4, IC50: 129 nM |
++
ALK5, IC50: 47 nM |
99%+ | ||||||||||||||||
| Vactosertib |
+++
ALK4, IC50: 13 nM |
+++
ALK5, IC50: 11 nM |
99%+ | ||||||||||||||||
| Alantolactone | ✔ | 98% | |||||||||||||||||
| (E/Z)-SIS3 free base | ✔ | 97% | |||||||||||||||||
| Pirfenidone | ✔ | 98% | |||||||||||||||||
| Hesperetin | ✔ | 97% | |||||||||||||||||
| RepSox |
++++
TGFβR1(ALK5), IC50: 4 nM |
98% | |||||||||||||||||
| GW788388 |
+++
ALK5, IC50: 18 nM |
98% | |||||||||||||||||
| LY364947 |
++
TGFβRI, IC50: 59 nM |
+
TGFβRII, IC50: 0.4 μM |
98% | ||||||||||||||||
| SD-208 |
++
TGF-βRI (ALK5), IC50: 48 nM |
99% | |||||||||||||||||
| SB-525334 |
+++
TGFβR1(ALK5), IC50: 14.3 nM |
99%+ | |||||||||||||||||
| LY2109761 |
++
TβRI, Ki: 38 nM |
+
TβRII, Ki: 300 nM |
99%+ | ||||||||||||||||
| Galunisertib |
++
TβRI, IC50: 56 nM |
98% | |||||||||||||||||
| SB 431542 |
+
ALK5, IC50: 94 nM |
99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 产品名称 | Potassium Channel ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tolbutamide | ✔ | 98% | |||||||||||||||||
| Glimepiride |
++++
SUR1, IC50: 5.4 nM SUR2B, IC50: 7.3 nM |
97% | |||||||||||||||||
| Dronedarone HCl | ✔ | 95% | |||||||||||||||||
| Gliquidone |
++
Potassium channel, IC50: 27.2 nM |
99% | |||||||||||||||||
| TRAM-34 |
+++
IKCa1 (KCa3.1), Kd: 20 nM |
98% | |||||||||||||||||
| Glibenclamide | ✔ | 98% | |||||||||||||||||
| Amiodarone HCl | ✔ | 97% | |||||||||||||||||
| Gliclazide |
++
Potassium channel, IC50: 184 nM |
98% | |||||||||||||||||
| Repaglinide | ✔ | 98% | |||||||||||||||||
| Dofetilide | ✔ | 98% | |||||||||||||||||
| Nateglinide | ✔ | 99% | |||||||||||||||||
| Quinine HCl dihydrate | ✔ | 98% | |||||||||||||||||
| ML133 HCl |
+
Kir2.1, IC50: 290 nM |
99% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 产品名称 | PKC ↓ ↑ | PKCα ↓ ↑ | PKCβ ↓ ↑ | PKCγ ↓ ↑ | PKCδ ↓ ↑ | PKCε ↓ ↑ | PKCζ ↓ ↑ | PKCη ↓ ↑ | PKCθ ↓ ↑ | 其他靶点 | 纯度 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Daphnetin |
+
PKC, IC50: 25.01 μM |
EGFR,PKA | 95% | ||||||||||||||||
| Dequalinium Chloride | 99%+ | ||||||||||||||||||
| Quercetin | ✔ | Sirtuin,Src | 95% | ||||||||||||||||
| Myricetrin | ✔ | 96% | |||||||||||||||||
| Go 6983 |
+++
PKCα, IC50: 7 nM |
+++
PKCβ, IC50: 7 nM |
+++
PKCγ, IC50: 6 nM |
+++
PKCδ, IC50: 10 nM |
++
PKCζ, IC50: 60 nM |
99%+ | |||||||||||||
| Go6976 |
+++
PKC, IC50: 7.9 nM |
++++
PKCα, IC50: 2.3 nM |
+++
PKCβ1, IC50: 6.2 nM |
FLT3 | 99%+ | ||||||||||||||
| Bisindolylmaleimide I |
+++
PKCα, IC50: 20 nM |
+++
PKCβ2, IC50: 16 nM PKCβ1, IC50: 17 nM |
+++
PKCγ, IC50: 20 nM |
99%+ | |||||||||||||||
| Lawsone methyl ether | ✔ | 99% | |||||||||||||||||
| Sotrastaurin |
++++
PKCα, Ki: 0.95 nM |
++++
PKCβ1, Ki: 0.64 nM |
++++
PKCδ, Ki: 2.1 nM |
++++
PKCε, Ki: 3.2 nM |
++++
PKCη, Ki: 1.8 nM |
++++
PKCθ, Ki: 0.22 nM |
99%+ | ||||||||||||
| Enzastaurin |
++
PKCα, IC50: 39 nM |
+++
PKCβ, IC50: 6 nM |
+
PKCγ, IC50: 83 nM |
+
PKCε, IC50: 110 nM |
98% | ||||||||||||||
| Midostaurin |
++
PKCα, IC50: 22 nM |
++
PKCβ2, IC50: 31 nM PKCβ1, IC50: 30 nM |
++
PKCγ, IC50: 24 nM |
+
PKCδ, IC50: 330 nM |
+
PKCε, IC50: 1.25 μM |
+
PKCη, IC50: 160 nM |
99% | ||||||||||||
| Ro 31-8220 mesylate |
++++
PKCα, IC50: 5 nM |
+++
PKCβ2, IC50: 14 nM PKCβ1, IC50: 24 nM |
++
PKCγ, IC50: 27 nM |
++
PKCε, IC50: 24 nM |
99%+ | ||||||||||||||
| Staurosporine |
++++
PKCα, IC50: 2 nM |
++++
PKCγ, IC50: 5 nM |
+++
PKCδ, IC50: 20 nM |
++
PKCε, IC50: 73 nM |
++++
PKCη, IC50: 4 nM |
99%+ | |||||||||||||
| Ruboxistaurin HCl |
+
PKCα, IC50: 0.36 μM |
++++
PKCβ2, IC50: 5.9 nM PKCβ1, IC50: 4.7 nM |
+
PKCγ, IC50: 0.3 μM |
+
PKCδ, IC50: 0.25 μM |
++
PKCη, IC50: 0.052 μM |
99%+ | |||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Dequalinium chloride (DECA), a cationic, lipophilic mitochondrial poison, selectively targets the mitochondrial membrane of certain epithelial carcinoma cells, in which it inhibits cellular energy production. After a single ip administration, we found a maximum tolerated dose of 15 mg/kg and a lethal dose (LD50) of 18.3 mg/kg. Single ip doses of 20 and 25 mg/kg produced > 50% mortality[3]. The compound antagonized M3 mACHRs (M3 muscarinic receptor) with an IC50 of 0.27 μM for dequalinium chloride[4]. Dequalinium chloride (DQC) is an anti-microbial antiseptic agent with a broad bactericidal and fungicidal activity. Vaginal DQC (Fluomizin vaginal tablets) has been shown to have equal clinical efficacy as clindamycin in the treatment of BV(bacterial vaginosis)[5]. Dequalinium chloride inhibits and kills clinical isolates of A. vaginae at concentrations similar to those of clindamycin and lower than those of metronidazole[6]. |
| Concentration | Treated Time | Description | References | |
| HEK 293 cells | 30 μM | Inhibited TRPM7-mediated Ca2+ influx | Br J Pharmacol. 2012 Jun;166(4):1357-76. | |
| 293T cells | 10 μM | 24 hours | Screening FDA-approved drug library for compounds that interfere with Cdc7-Dbf4 interaction | EBioMedicine. 2018 Oct;36:241-251. |
| African green monkey kidney epithelial cell line CV-1 | 250 μM | 3 hours | Evaluate the toxicity of Dequalinium to CV-1 cells, showing an IC50 of 250 μM | Proc Natl Acad Sci U S A. 1987 Aug;84(15):5444-8. |
| Human breast carcinoma cell line MCF-7 | 2 μM | 3 hours | Evaluate the toxicity of Dequalinium to MCF-7 cells, showing an IC50 of 2 μM, 125-fold more toxic than CV-1 cells | Proc Natl Acad Sci U S A. 1987 Aug;84(15):5444-8. |
| NB TICs (NB12, NB88R2, NB122R) | 100 nM | 72 hours | Significantly reduced cell viability and induced apoptosis | EMBO Mol Med. 2010 Sep;2(9):371-84. |
| NB TICs (NB12) | 100 nM | 24 hours | Induced apoptosis, characterized by nuclear morphology changes and increased sub-2n DNA content | EMBO Mol Med. 2010 Sep;2(9):371-84. |
| Yeast cells | 0.7-4 μM | 24 hours | DECA inhibits Su9-Ura3 import into mitochondria | Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):14406-11. |
| CHO-K1 cells | 2-10 μM | 4 hours | DECA inhibits mitochondrial protein translocation and restores AGTP11LG170R trafficking to peroxisomes | Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):14406-11. |
| Rat cultured sympathetic neurones | 0.60 ± 0.05 μM | 1-3 minutes | To evaluate the inhibitory effect of Dequalinium on SKCa channels in sympathetic neurones, results showed that Dequalinium effectively inhibited the slow afterhyperpolarization (AHP). | Br J Pharmacol. 1996 Jan;117(1):35-42. |
| HEK293 cells | 0.4 μM | Investigated the blocking effect of Dequalinium on hSK1 current, with an IC50 of 0.48 μM. | Br J Pharmacol. 2000 Feb;129(4):627-30. | |
| Rat superior cervical ganglion (SCG) neurones | 0.62 μM | Test the inhibitory effect of Dequalinium on SK Ca channels, results showed weak inhibition | Br J Pharmacol. 2000 Apr;129(7):1431-8. | |
| Rabbit blood cells | 410 μM | Test the inhibitory effect of Dequalinium on IK Ca channels, results showed weak inhibition | Br J Pharmacol. 2000 Apr;129(7):1431-8. | |
| OEC-M1 cells | 2 μM | 48 hours | Evaluating the inhibitory effect of Dequalinium chloride on Cdc7-Dbf4 kinase activity | EBioMedicine. 2018 Oct;36:241-251. |
| HEK 293 cells | 444 nM | To investigate the inhibitory effect of Dequalinium Chloride on hSK1 and rSK2 channels, showing IC50 values of 444 nM and 162 nM for hSK1 and rSK2, respectively. | Br J Pharmacol. 2000 Mar;129(5):991-9. | |
| Administration | Dosage | Frequency | Description | References | ||
| BALB/c nude mice | Subcutaneous OEC-M1 oral carcinoma xenograft model | Oral administration | 15 mg/kg | Twice a week for six consecutive weeks | Evaluating the antitumor activity of Dequalinium chloride in vivo | EBioMedicine. 2018 Oct;36:241-251. |
| BDF1 mice | I.p. implanted mouse bladder carcinoma MB49 | Intraperitoneal injection | 2 mg/kg or 4 mg/kg | Daily or every other day for 25 days | Evaluate the survival prolongation effect of Dequalinium on MB49 tumors, showing a T/C (treated/control ratio) of 190%, more effective than seven anticancer drugs | Proc Natl Acad Sci U S A. 1987 Aug;84(15):5444-8. |
| Zebrafish | Embryonic development model | Solution treatment | 20 μM | 3 days | DECA does not affect zebrafish embryonic development at low concentrations | Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):14406-11. |
| Rats | PGE2-induced hyperalgesia model | Subcutaneous injection | 50 mg/paw | Single administration, measured after 30 minutes | To evaluate the effect of Dequalinium on baclofen-induced peripheral antinociception, results showed no significant effect | Br J Pharmacol. 2006 Nov;149(6):733-9 |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT02242695 | Vulvovaginal Candidiasis | Phase 4 | Completed | - | Thailand ... 展开 >> Siriraj Gynaecologic ID and Female STD Unit, Department of Obstetrics & Gynaecology, Faculty of Medicine Siriraj Hospital, Mahidol University Bangkok, Bangkok Noi district, Thailand, 10700 收起 << |
| NCT01125410 | Bacterial Vaginosis | Phase 3 | Completed | - | Belgium ... 展开 >> AZ Imelda Ziekenhuis Bonheiden, Belgium AZ St. Dimpna Geel, Belgium AZ Ziekenhuis Oost-Limburg Genk, Belgium AZ Heilig Hart Tienen, Belgium Czech Republic Centrum Ambulantni gynekologie a prodnictvi Brno, Czech Republic Faculty Hospital Brno Brno, Czech Republic University Hospital Hradec Kralove Hradec Kralove, Czech Republic Charles University Prague, Czech Republic Fakultni nemocnice Na Bulovce Prague, Czech Republic Ambulance pro gynekologie a prodnictvi Telc, Czech Republic Germany LMU Munich Munich, Germany Slovakia JLF UK a MFN Martin, Slovakia Switzerland University Hospital of Geneva and Faculty of Medicine Geneva, Switzerland CHUV Lausanne, Switzerland 收起 << |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.90mL 0.38mL 0.19mL |
9.48mL 1.90mL 0.95mL |
18.95mL 3.79mL 1.90mL |
|
| CAS号 | 522-51-0 |
| 分子式 | C30H40Cl2N4 |
| 分子量 | 527.57 |
| SMILES Code | CC1=[N+](C2=CC=CC=C2C(N)=C1)CCCCCCCCCC[N+](C3=CC=CC=C3C(N)=C4)=C4C.[Cl-].[Cl-] |
| MDL No. | MFCD00063502 |
| 别名 | Dequalinium (chloride); NSC 166454; Dequavagyn |
| 运输 | 蓝冰 |
| InChI Key | LTNZEXKYNRNOGT-UHFFFAOYSA-N |
| Pubchem ID | 10649 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, 2-8°C |
| 溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1